LLY

766.38

+2.78%↑

JNJ

177.06

-0.18%↓

ABBV

216.94

+1.09%↑

UNH

342.77

-1.67%↓

AZN

77.82

+0.31%↑

LLY

766.38

+2.78%↑

JNJ

177.06

-0.18%↓

ABBV

216.94

+1.09%↑

UNH

342.77

-1.67%↓

AZN

77.82

+0.31%↑

LLY

766.38

+2.78%↑

JNJ

177.06

-0.18%↓

ABBV

216.94

+1.09%↑

UNH

342.77

-1.67%↓

AZN

77.82

+0.31%↑

LLY

766.38

+2.78%↑

JNJ

177.06

-0.18%↓

ABBV

216.94

+1.09%↑

UNH

342.77

-1.67%↓

AZN

77.82

+0.31%↑

LLY

766.38

+2.78%↑

JNJ

177.06

-0.18%↓

ABBV

216.94

+1.09%↑

UNH

342.77

-1.67%↓

AZN

77.82

+0.31%↑

Search

Microbot Medical Inc

Open

3.48 1.46

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3.38

Max

3.55

Belangrijke statistieken

By Trading Economics

Inkomsten

-899K

-3.5M

Winstmarge

-4,038.095

Werknemers

20

EBITDA

-84K

-3.5M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+196.3% upside

Dividenden

By Dow Jones

Volgende Winsten

11 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

90M

218M

Vorige openingsprijs

2.02

Vorige sluitingsprijs

3.48

Technische score

By Trading Central

Vertrouwen

Neutral Evidence

Microbot Medical Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

15 sep 2025, 22:39 UTC

Acquisities, Fusies, Overnames

CSL Agrees to Deal to Advance Coagulation Treatment, May Acquire Developer

15 sep 2025, 16:43 UTC

Belangrijke Marktbewegers

Strive Shares Sink on Board Disclosure; Bitcoin Treasury Strategy

15 sep 2025, 16:42 UTC

Belangrijke Marktbewegers

Helius Medical Tech Jumps on Funding to Launch Solana Treasury

15 sep 2025, 16:35 UTC

Belangrijke Marktbewegers

Chegg to Pay $7.5 Million to Settle FTC Claims Over Subscription Cancellation Process

15 sep 2025, 23:46 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

15 sep 2025, 23:46 UTC

Marktinformatie

Nikkei May Rise as Fed Rate Cut Hopes Support Stocks -- Market Talk

15 sep 2025, 23:34 UTC

Marktinformatie

Gold Steady Ahead of FOMC Meeting, Major U.S. Economic Data -- Market Talk

15 sep 2025, 22:48 UTC

Marktinformatie

FOMC May Opt to Play Catch Up With Rate Cuts -- Market Talk

15 sep 2025, 22:12 UTC

Acquisities, Fusies, Overnames

CSL Expects Commercial Launch in 2029

15 sep 2025, 22:12 UTC

Acquisities, Fusies, Overnames

CSL Says VarmX to Receive Further Commercial Milestones Afterwards

15 sep 2025, 22:11 UTC

Acquisities, Fusies, Overnames

CSL Says VarmX to Receive Payments of Up to $388 Million Up to Launch of VMX-C001

15 sep 2025, 22:11 UTC

Acquisities, Fusies, Overnames

CSL to Have Right to Exercise Option Based on Phase 3 Data

15 sep 2025, 22:10 UTC

Acquisities, Fusies, Overnames

CSL to Make Upfront Payment to VarmX of $117 Million for Exclusive Option to Acquire Company

15 sep 2025, 21:16 UTC

Acquisities, Fusies, Overnames

Chord Energy: Assets Have a Low Avg NYMEX WTI Breakeven and Are Immediately Competitive for Capital

15 sep 2025, 21:16 UTC

Acquisities, Fusies, Overnames

Chord Energy: Assets Have Significant Overlap With Existing Footprint, Setting the Stage for Long-Lateral Development

15 sep 2025, 21:15 UTC

Acquisities, Fusies, Overnames

Chord Energy to Buy 48,000 Net Acres in the Williston Core

15 sep 2025, 21:14 UTC

Acquisities, Fusies, Overnames

Chord Energy to Buy Assets in Williston Basin From Exxon's XTO Energy and Affiliates for $550M

15 sep 2025, 20:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

15 sep 2025, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

15 sep 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

15 sep 2025, 19:29 UTC

Marktinformatie

U.S. Natural Gas Gains on Warmer Weather Outlook -- Market Talk

15 sep 2025, 19:14 UTC

Marktinformatie

Attacks on Russia Lifts Oil Price Despite Shaky Fundamentals -- Market Talk

15 sep 2025, 18:16 UTC

Marktinformatie

Gold Powers to New High -- Market Talk

15 sep 2025, 18:05 UTC

Marktinformatie

Easing Autonomous Vehicle Regulations Will Begin Tesla's Next Chapter -- Market Talk

15 sep 2025, 17:50 UTC

Acquisities, Fusies, Overnames

U.S. Reaches Outline of Deal With China Over TikTok -- 2nd Update

15 sep 2025, 17:10 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

15 sep 2025, 17:10 UTC

Marktinformatie

S&P Expects Fed, BOC to Cut Rates -- Market Talk

15 sep 2025, 16:52 UTC

Marktinformatie

Copper Climbs as Traders Brace for U.S. Rate Cut -- Market Talk

15 sep 2025, 16:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

15 sep 2025, 16:20 UTC

Marktinformatie
Winsten

Auto & Transport Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Microbot Medical Inc Prognose

Koersdoel

By TipRanks

196.3% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 12 USD  196.3%

Hoogste 12 USD

Laagste 12 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Microbot Medical Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Technische score

By Trading Central

2.52 / 2.57Steun & Weerstand

Korte Termijn

Neutral Evidence

Gemiddeld Termijn

Very Strong Bullish Evidence

Lange Termijn

Weak Bullish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.
help-icon Live chat